ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Biogen completes Nightstar acquisition pharmatimes
June 11, 2019Biogen has announced that it has completed its acquisition of Sycona’s Nightstar Therapeutics, the clinical-stage gene therapy company, which is focused on adeno-associated virus (AAV) treatments for inherited retinal disorders.
Pharma Sources Insight January 2025
